TI - Molecular cloning of a novel human CC chemokine ( <p1  pair=1 >  <prot>  Eotaxin - 3 </prot>  </p1>  ) that is a functional ligand of <p2  pair=1 >  <prot>  CC chemokine receptor 3 </prot>  </p2>  .
PG - 27975 - 80 AB - Previously , we mapped the novel CC chemokine <prot>  myeloid progenitor inhibitory factor 2 </prot>  ( <prot>  MPIF - 2 </prot>  ) / <prot>  eotaxin - 2 </prot>  to chromosome 7q11.23 ( Nomiyama , H. , Osborne , L. R. , Imai , T. , Kusuda , J. , Miura , R. , Tsui , L. - C. , and Yoshie , O. ( 1998 ) Genomics 49 , 339 - 340 ) .
Since chemokine genes tend to be clustered , unknown chemokines may be present in the vicinity of those mapped to new chromosomal loci .
Prompted by this hypothesis , we analyzed the genomic region containing the gene for <prot>  MPIF - 2 </prot>  / <prot>  eotaxin - 2 </prot>  ( <prot>  SCYA24 </prot>  ) and have identified a novel CC chemokine termed <prot>  eotaxin - 3 </prot>  .
The genes for <prot>  MPIF - 2 </prot>  / <prot>  eotaxin - 2 </prot>  ( <prot>  SCYA24 </prot>  ) and <prot>  eotaxin - 3 </prot>  ( <prot>  SCYA26 </prot>  ) are localized within a region of approximately 40 kilobases .
By Northern blot analysis , <prot>  eotaxin - 3 </prot>  mRNA was constitutively expressed in the heart and ovary .
We have generated recombinant <prot>  eotaxin - 3 </prot>  in a baculovirus expression system .
 <prot> Eotaxin - 3 </prot>  induced transient calcium mobilization specifically in <prot>  CC chemokine receptor 3 </prot>  ( <prot>  CCR3 </prot>  ) - expressing L1.2 cells with an EC ( 50 ) of 3 nM .
 <p1  pair=2 >  <prot> Eotaxin - 3 </prot>  </p1>  competed the binding of ( 125 ) <p1  pair=3 >  <prot>  I - eotaxin </prot>  </p1>  to <p2  pair=2 >  <p2  pair=3 >  <prot>  CCR3 </prot>  </p2>  </p2>  - expressing L1.2 cells with an IC ( 50 ) of 13 nM .
 <prot> Eotaxin - 3 </prot>  was chemotactic for normal peripheral blood eosinophils and basophils at high concentrations .
Collectively , <p1  pair=4 >  <prot>  eotaxin - 3 </prot>  </p1>  is yet another functional ligand for <p2  pair=4 >  <prot>  CCR3 </prot>  </p2>  .
The potency of <p1  pair=5 >  <prot>  eotaxin - 3 </prot>  </p1>  as a <p1  pair=6 >  <p2  pair=5 >  <prot>  CCR3 </prot>  </p2>  </p1>  ligand seems , however , to be approximately 10 - fold less than that of <p2  pair=6 >  <prot>  eotaxin </prot>  </p2>  .
Identification of <prot>  eotaxin - 3 </prot>  will further promote our understanding of the control of eosinophil trafficking and other <prot>  CCR3 </prot>  - mediated biological phenomena .
The strategy used in this study may also be applicable to identification of other unknown chemokine genes .
AD - Shionogi Institute for Medical Science , Osaka 566 - 0022 , Kinki University
